发布求助
文献互助 智能选刊 最新文献

Evidence-Based Medicine最新文献

筛选
英文 中文
Evaluation of a 0-hour/1-hour algorithm in the diagnosis of myocardial infarction with high-sensitivity cardiac troponin T1. 高灵敏度心肌肌钙蛋白T1诊断心肌梗死的0小时/1小时算法评价
Evidence-Based Medicine Pub Date : 2017-12-01 Epub Date: 2017-11-17 DOI: 10.1136/ebmed-2017-110830
Jaspreet Kaur Khaira
{"title":"Evaluation of a 0-hour/1-hour algorithm in the diagnosis of myocardial infarction with high-sensitivity cardiac troponin T1.","authors":"Jaspreet Kaur Khaira","doi":"10.1136/ebmed-2017-110830","DOIUrl":"https://doi.org/10.1136/ebmed-2017-110830","url":null,"abstract":"Using a highly sensitive assay of serum troponin T in patients with suspected myocardial infarction might help in early diagnosis, but the method needs thorough clinical assessment before implementation.\u0000\u0000### Summary box\u0000\u0000The High Sensitivity Cardiac Troponin T Assay for Rapid Rule-out of Acute Myocardial Infarction trial was a prospective, multicentre, diagnostic study done at 12 sites, across three continents to validate the diagnostic accuracy of the troponin T 0-hour/1-hour algorithm for rule-in and rule-out of acute myocardial infarction.1 \u0000\u0000Current troponin assays for the diagnosis of myocardial infarction usually require serial sampling between 8 and 24 hours, depending on the specific assay/local protocols. This time interval contributes to ‘rule-in’ delays, delaying treatment, and ‘rule-out’ delays, costing time, …","PeriodicalId":12182,"journal":{"name":"Evidence-Based Medicine","volume":" ","pages":"235-236"},"PeriodicalIF":0.0,"publicationDate":"2017-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1136/ebmed-2017-110830","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35563792","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Journal Clubs: 2. Why and how to run them and how to publish them. 期刊俱乐部:2;为什么以及如何运行它们以及如何发布它们。
Evidence-Based Medicine Pub Date : 2017-12-01 Epub Date: 2017-11-17 DOI: 10.1136/ebmed-2017-110861
Jeffrey K Aronson
{"title":"Journal Clubs: 2. Why and how to run them and how to publish them.","authors":"Jeffrey K Aronson","doi":"10.1136/ebmed-2017-110861","DOIUrl":"https://doi.org/10.1136/ebmed-2017-110861","url":null,"abstract":"Journal clubs have many functions, including the provision of a forum for developing skills in critical appraisal, an essential part of being a competent clinician.\u0000\u0000From early on, journal clubs reported their proceedings in academic journals. The Zoological Journal Club of Michigan , for example, regularly reported its activities in the journal Science (see figure 1). Table 1 lists a selection of other journals that publish journal club articles, showing the wide range of topics covered. Modern methods of conducting journal clubs include the use of online media to encourage interactive discussion,1 including blogs,2 twitter,3 and virtual journal clubs.4 \u0000\u0000\u0000\u0000Figure 1 \u0000The contents page of Science for Friday 7 December 1900, listing the proceedings of the Zoological Journal Club of the University of Michigan .\u0000\u0000\u0000\u0000View this table:\u0000\u0000Table 1 \u0000Some journals that publish articles under the heading ‘Journal Club’\u0000\u0000\u0000\u0000It is therefore appropriate that Evidence-Based Medicine  (EBM) should feature a regular journal club report.\u0000\u0000In order to find out how others run journal clubs and the effects that they …","PeriodicalId":12182,"journal":{"name":"Evidence-Based Medicine","volume":" ","pages":"232-234"},"PeriodicalIF":0.0,"publicationDate":"2017-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1136/ebmed-2017-110861","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35563795","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 17
Unblinded ASCOT study results do not rule out that muscle symptoms are an adverse effect of statins. 非盲ASCOT研究结果不排除肌肉症状是他汀类药物的不良反应。
Evidence-Based Medicine Pub Date : 2017-12-01 Epub Date: 2017-10-22 DOI: 10.1136/ebmed-2017-110783
Bhavin B Adhyaru, Terry A Jacobson
{"title":"Unblinded ASCOT study results do not rule out that muscle symptoms are an adverse effect of statins.","authors":"Bhavin B Adhyaru, Terry A Jacobson","doi":"10.1136/ebmed-2017-110783","DOIUrl":"https://doi.org/10.1136/ebmed-2017-110783","url":null,"abstract":"Commentary on : Gupta A and ASCOT investigators. Adverse events associated with unblinded, but not with blinded, statin therapy in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid-Lowering Arm (ASCOT-LLA): a randomised double-blind placebo-controlled trial and its non-randomised non-blind extension phase. Lancet 2017;389:2473–81.\u0000\u0000Several studies suggest that the low adherence rates with statin therapy are related to adverse events, particularly statin-associated muscle symptoms (SAMS).1 Rates of SAMS are found to be much higher in observational studies (10%–20%) compared with randomised controlled trials (RCTs) (1%–3%), which often find little difference in adverse events between statin and placebo groups.2 3 This study, having both blinded and unblinded phases, offers a unique perspective in looking at adverse events with statin therapy.\u0000\u0000The first trial phase was a randomised, blinded phase that included 10 180 patients aged 40–79 years with …","PeriodicalId":12182,"journal":{"name":"Evidence-Based Medicine","volume":" ","pages":"210"},"PeriodicalIF":0.0,"publicationDate":"2017-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1136/ebmed-2017-110783","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35535244","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Adjunctive antibiotics for drained skin abscesses improve clinical cure rate. 皮肤脓肿引流辅助抗生素治疗提高临床治愈率。
Evidence-Based Medicine Pub Date : 2017-12-01 Epub Date: 2017-10-11 DOI: 10.1136/ebmed-2017-110815
David A Talan
{"title":"Adjunctive antibiotics for drained skin abscesses improve clinical cure rate.","authors":"David A Talan","doi":"10.1136/ebmed-2017-110815","DOIUrl":"https://doi.org/10.1136/ebmed-2017-110815","url":null,"abstract":"Commentary on : Daum RS, Miller LG, Immergluck LA, et al . Placebo-controlled trial of antibiotics for smaller skin abscesses. N Engl J Med 2017;376:2545–55.\u0000\u0000The primary treatment of a skin abscess is drainage. Past studies of adjunctive antibiotic treatment conducted before and after the emergence of community-associated methicillin-resistant Staphylococcus aureus (MRSA) in the USA and other parts of the world were small and did not clearly demonstrate benefit. In 2016, Talan et al 1 reported a US randomised placebo-controlled trial (RCT) among 1265 mostly adults, including some with co-morbidities, which demonstrated that treatment with an antibiotic possessing in vitro activity against MRSA, trimethoprim–sulfamethoxazole (TMP-SMX), was associated with a significantly higher short-term cure rate among patients with a drained skin abscess ≥2 cm in diameter. TMP-SMX-treated participants also had fewer additional drainage procedures and new site skin infections through 4–6 post-treatment. Overall adverse event rates were similar, with slightly …","PeriodicalId":12182,"journal":{"name":"Evidence-Based Medicine","volume":" ","pages":"214"},"PeriodicalIF":0.0,"publicationDate":"2017-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1136/ebmed-2017-110815","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35441511","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Don't put off until tomorrow what you can do today: Early cholecystectomy is cost-effective in symptomatic cholelithiasis requiring hospitalization. 不要把今天能做的事拖到明天:对于需要住院治疗的有症状的胆石症患者，早期胆囊切除术是划算的。
Evidence-Based Medicine Pub Date : 2017-12-01 DOI: 10.1136/ebmed-2016-110633
Charles de Mestral
{"title":"Don't put off until tomorrow what you can do today: Early cholecystectomy is cost-effective in symptomatic cholelithiasis requiring hospitalization.","authors":"Charles de Mestral","doi":"10.1136/ebmed-2016-110633","DOIUrl":"https://doi.org/10.1136/ebmed-2016-110633","url":null,"abstract":"Commentary on : Sutton AJ, Vohra RS, Hollyman M, et al . Cost-effectiveness of emergency versus delayed laparoscopic cholecystectomy for acute gallbladder pathology. Br J Surg 2016;104:98–107.\u0000\u0000Randomised trial and population-based data support the clinical benefit of early over delayed laparoscopic cholecystectomy for acute cholecystitis.1 Concern of increased risk of major bile duct injury or death with early surgery in the setting of acute inflammation has been refuted and there is 20%–30% risk of recurrent gallstone symptoms if surgery is delayed.2 Early and delayed surgery have also been previously compared with economic models informed by randomised controlled trial and population-based data. While most studies have focused on acute cholecystitis, Sutton and colleagues have considered patients across the spectrum of symptomatic cholelithiasis—biliary colic and cholecystitis—requiring hospitalisation.\u0000\u0000This study …","PeriodicalId":12182,"journal":{"name":"Evidence-Based Medicine","volume":"22 6","pages":"221"},"PeriodicalIF":0.0,"publicationDate":"2017-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1136/ebmed-2016-110633","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9213423","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Interpreting diagnostic tests with continuous results and no gold standard: a common scenario explained using the tuberculin skin test. 解释具有连续结果且无金标准的诊断试验:使用结核菌素皮肤试验解释的常见情况。
Evidence-Based Medicine Pub Date : 2017-12-01 Epub Date: 2017-10-22 DOI: 10.1136/ebmed-2017-110825
Claudia C Dobler, M Hassan Murad
{"title":"Interpreting diagnostic tests with continuous results and no gold standard: a common scenario explained using the tuberculin skin test.","authors":"Claudia C Dobler,&nbsp;M Hassan Murad","doi":"10.1136/ebmed-2017-110825","DOIUrl":"https://doi.org/10.1136/ebmed-2017-110825","url":null,"abstract":"<p><p>Practitioners of evidence-based medicine commonly encounter diagnostic tests with continuous results and no gold standard. In contrast, the traditional critical appraisal teachings assume a binary test (2×2 table) with a gold standard. In this guide, we use the example of the tuberculin skin test to illustrate a simple approach facilitated by using stratum-specific likelihood ratios and odds of developing future patient-important events. This approach can aid practitioners in the interpretation and application of diagnostic tests to patient care.</p>","PeriodicalId":12182,"journal":{"name":"Evidence-Based Medicine","volume":" ","pages":"199-201"},"PeriodicalIF":0.0,"publicationDate":"2017-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1136/ebmed-2017-110825","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35535241","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
SOFA criteria predict infection-related in-hospital mortality in ICU patients better than SIRS criteria and the qSOFA score. SOFA标准对ICU患者感染相关住院死亡率的预测优于SIRS标准和qSOFA评分。
Evidence-Based Medicine Pub Date : 2017-12-01 Epub Date: 2017-11-10 DOI: 10.1136/ebmed-2017-110727
Erik Solligård, Jan Kristian Damås
{"title":"SOFA criteria predict infection-related in-hospital mortality in ICU patients better than SIRS criteria and the qSOFA score.","authors":"Erik Solligård,&nbsp;Jan Kristian Damås","doi":"10.1136/ebmed-2017-110727","DOIUrl":"https://doi.org/10.1136/ebmed-2017-110727","url":null,"abstract":"Commentary on : Raith EP, Udy AA, Bailey M, et al . Prognostic accuracy of the SOFA score, SIRS criteria, and qSOFA score for in-hospital mortality among adults with suspected infection admitted to the intensive care unit. JAMA 2017;317:290–300.\u0000\u0000The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) has redefined sepsis, now defining sepsis as a life-threatening organ dysfunction caused by a dysregulated host response to infection, with organ failure defined as a two-or-more-point change in the Sequential Organ Failure Assessment (SOFA) score.1 The new sepsis definition was determined in a retrospective cohort of both intensive care unit (ICU) and non-ICU encounters.2 The quick SOFA (qSOFA) score (altered mentation, systolic blood pressure ≤100 mm Hg and respiratory rate ≥22/min) was also introduced as a possible useful predictive tool among patients outside the ICU.\u0000\u0000This external validation study compares the discrimination …","PeriodicalId":12182,"journal":{"name":"Evidence-Based Medicine","volume":" ","pages":"211"},"PeriodicalIF":0.0,"publicationDate":"2017-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1136/ebmed-2017-110727","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35543509","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 10
Controversies in PSA screening. PSA筛查的争议。
Evidence-Based Medicine Pub Date : 2017-12-01 Epub Date: 2017-11-09 DOI: 10.1136/ebmed-2017-110858
Jack O'Sullivan
{"title":"Controversies in PSA screening.","authors":"Jack O'Sullivan","doi":"10.1136/ebmed-2017-110858","DOIUrl":"https://doi.org/10.1136/ebmed-2017-110858","url":null,"abstract":"Forty years after its discovery, a reanalysis of the two largest trials to date, controversially suggests that prostate-specific antigen (PSA) screening may actually be beneficial.\u0000\u0000Most healthcare organisations do not recommend PSA screening for prostate cancer,1 2 mainly in response to conflicting evidence about the benefits and clear evidence of harms. PSA can lead to false positive or ‘overdiagnosed’ cancer (detecting prostate cells that histologically represent cancer, but will never grow to cause a patient harm).\u0000\u0000Evidence regarding efficacy has been based on two large randomised controlled trials: The European Randomised Study of Screening for Prostate Cancer (ERSPC)3 and Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO).4 These trials are both considered to be of high quality, but the trials came to …","PeriodicalId":12182,"journal":{"name":"Evidence-Based Medicine","volume":" ","pages":"198"},"PeriodicalIF":0.0,"publicationDate":"2017-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1136/ebmed-2017-110858","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35593209","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 7
Minimal difference in survival between radical prostatectomy and observation in men with modest life expectancy. 根治性前列腺切除术与观察预期寿命中等男性的生存差异极小。
Evidence-Based Medicine Pub Date : 2017-12-01 Epub Date: 2017-11-10 DOI: 10.1136/ebmed-2017-110837
Vignesh T Packiam, Scott E Eggener
{"title":"Minimal difference in survival between radical prostatectomy and observation in men with modest life expectancy.","authors":"Vignesh T Packiam,&nbsp;Scott E Eggener","doi":"10.1136/ebmed-2017-110837","DOIUrl":"https://doi.org/10.1136/ebmed-2017-110837","url":null,"abstract":"Commentary on : Wilt TJ, Jones KM, Barry MJ, et al . Follow-up of prostatectomy versus observation for early prostate cancer. N Engl J Med 2017;377:132–42.\u0000\u0000Screening, diagnosis and management of localised prostate cancer remains controversial.\u0000\u0000Prostate Cancer Intervention Versus Observation Trial (PIVOT) was a randomised controlled trial that accrued 731 men with prostate cancer (PCa) between 1994 and 2002 from Veterans Affairs hospitals. Patients were randomised to radical prostatectomy (n=364) or observation (n=367). Inclusion criteria was clinical stage T1–T2 (organ confined), prostate-specific antigen (PSA) 10 years. Primary and secondary outcomes were all-cause and prostate-cancer mortality.\u0000\u0000Median age was 67 years, median PSA 7.8 ng/mL and 45% of patients were clinical stage T2 (palpable on exam). After 19.5 years follow-up (median 12.7 years), cumulative all-cause mortality was similar between surgery and observation (61.3% vs 66.8%; HR 0.84; 95% CI 0.70 …","PeriodicalId":12182,"journal":{"name":"Evidence-Based Medicine","volume":" ","pages":"222"},"PeriodicalIF":0.0,"publicationDate":"2017-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1136/ebmed-2017-110837","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35543508","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Stent choice in cardiogenic shock complicating acute myocardial infarction likely does not affect mortality or reinfarction. 心源性休克并发急性心肌梗死的支架选择可能不会影响死亡率或再梗死。
Evidence-Based Medicine Pub Date : 2017-12-01 Epub Date: 2017-11-04 DOI: 10.1136/ebmed-2017-110841
Talla A Rousan, Udho Thadani
{"title":"Stent choice in cardiogenic shock complicating acute myocardial infarction likely does not affect mortality or reinfarction.","authors":"Talla A Rousan,&nbsp;Udho Thadani","doi":"10.1136/ebmed-2017-110841","DOIUrl":"https://doi.org/10.1136/ebmed-2017-110841","url":null,"abstract":"Commentary on:  Ledwoch J, Fuernau G, Desch S, et al . Drug-eluting stents versus bare-metal stents in acute myocardial infarction with cardiogenic shock. Heart 2017;103:1177–84.\u0000\u0000Early revascularisation improves acute and long-term outcomes of patients presenting with acute myocardial infarction (AMI) complicated by cardiogenic shock (CS). However, which type of stent to use for revascularisation remains controversial. Earlier small single-centre non-randomised study and registry data concluded that a drug-eluting stent (DES) is superior to a bare metal stent (BMS) as it improved clinical outcomes in these patients.1 2 Current European Society Guidelines recommend the use of DES, while American Society guidelines do not. This study examined the impact of BMS versus DES use on clinical outcomes in patients who had participated in the previously reported the Intra-aortic Balloon Pump (IABP) in Cardiogenic Shock II Trial (IABP-SHOCK II) which showed …","PeriodicalId":12182,"journal":{"name":"Evidence-Based Medicine","volume":" ","pages":"224"},"PeriodicalIF":0.0,"publicationDate":"2017-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1136/ebmed-2017-110841","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35522287","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信